LORI TIMBERLAKE: Open Payments
NPI 1831258383 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 93 payments from 11 companies in 2025. Trend: 2023 $287 · 2024 $295 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $498 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $320 |
| E.R. Squibb & Sons, L.L.C. | 10 | $273 |
| Axsome Therapeutics, Inc. | 1 | $104 |
| Indivior Inc. | 5 | $101 |
| Alkermes, Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $46 |
| Braeburn Inc. | 3 | $46 |
| Lundbeck LLC | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, COBENFY, Auvelity, SUBLOCADE, ABILIFY ASIMTUFII, FANAPT, BRIXADI.
Industry payments across OH — which companies pay providers there.
